Australia's most trusted
source of pharma news
Thursday, 12 March 2026
Posted 12 March 2026 AM
Pharmacor has opened a new front in its legal battle with AstraZeneca, taking a leaf from Sun Pharma's book.
In February Federal Court Justice Kylie Downes granted AstraZeneca a speedy interlocutory injunction against Pharmacor from launching a generic version of AZ's heart and kidney drug Forxiga on 1 April. The injunction also covered Xigduo, Qtern, and Sidapvia.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.